hepatopulmonary syndrome

**Definition (triad):** (1) Liver disease, most often cirrhosis with portal hypertension (can also occur in noncirrhotic portal hypertension and, rarely, acute liver disease). (2) Impaired gas exchange: A-a gradient ≥15 mmHg (≥20 mmHg if age >64) on room air, with or without hypoxemia (PaO2 <80 mmHg). (3) Intrapulmonary vascular dilatations (IPVDs) shown by contrast-enhanced echocardiography or macroaggregated albumin (MAA) lung perfusion scan.

**Pathophysiology:** - Portal hypertension and impaired hepatic clearance, plus gut bacterial translocation, lead to increased pulmonary production of vasodilators, especially nitric oxide (NO) via upregulated eNOS/iNOS. Endothelin-1 (ET-1) acting on ETB receptors and carbon monoxide (heme oxygenase-1) also contribute. Pulmonary macrophage accumulation and angiogenesis add to the process. - Result: dilated precapillary and capillary vessels (diameter up to 15–100 µm versus normal ~8–15 µm). - Gas exchange defect: V/Q mismatch and a diffusion-perfusion defect. Oxygen can't diffuse to the center of the dilated vessel, so RBCs in the center stay poorly oxygenated. True anatomic right-to-left shunts (arteriovenous communications) are less common. - Orthodeoxia and platypnea: IPVDs are predominantly in the lung bases. Upright posture increases basal perfusion, which worsens shunting and hypoxemia.

**Clinical features:** - Dyspnea, platypnea, orthodeoxia (PaO2 drop ≥5% or ≥4 mmHg upright versus supine) - Cyanosis, digital clubbing, spider angiomata (these correlate with HPS) - Stigmata of chronic liver disease - Hypoxemia is only partly corrected by supplemental O2 when the problem is diffusion-perfusion limited (shunt fraction is usually modest). Severe fixed shunts correct poorly with 100% O2.

**Diagnosis:** - Pulse oximetry screening (SpO2 <96% prompts ABG) - ABG on room air: elevated A-a gradient - Contrast (agitated saline) transthoracic echocardiography: bubbles appear in the left heart after 3–6 cardiac cycles (delayed, >3 beats), indicating a pulmonary rather than intracardiac shunt. Early appearance (within 3 beats) suggests an intracardiac shunt such as PFO. - Technetium-99m MAA scan: abnormal brain/kidney uptake (>6% suggests shunt) - Chest imaging is often normal or shows nodular basal opacities. Pulmonary angiography is reserved for selected cases. - PFTs: a reduced DLCO is common.

**Severity (by PaO2 on room air):** mild ≥80, moderate 60–79, severe 50–59, very severe <50 mmHg (<300 mmHg on 100% O2).

**Management:** - Liver transplantation is the only effective therapy. Hypoxemia typically resolves over months. HPS carries a MELD exception (priority points when PaO2 <60 mmHg), as it predicts increased mortality independent of MELD. - Supportive: supplemental O2. Medical therapies (e.g., garlic, methylene blue, somatostatin analogs, norfloxacin) are not proven. - TIPS and embolization of discrete AV malformations have limited, anecdotal roles.

**High-yield comparisons:** - **Portopulmonary hypertension (PoPH):** Also occurs with portal hypertension but involves pulmonary vasoCONSTRICTION and remodeling (increased PVR, mPAP >20 mmHg, PVR >3 WU, PAWP ≤15). It presents with dyspnea and right heart strain, and is treated with pulmonary vasodilators (prostacyclins, endothelin antagonists, PDE5 inhibitors). Transplant is risky if mPAP is >35–45 mmHg. Remember: HPS = vasodilation, PoPH = vasoconstriction. - **Hepatic hydrothorax:** Ascites transmitted across diaphragmatic defects (usually right-sided). - **Platypnea-orthodeoxia** also occurs with PFO/ASD and an elongated aorta/right-sided pressure changes. In cirrhosis, think HPS.

**Board pearls:** A cirrhotic patient with dyspnea worse when sitting up, clubbing, spider angiomata, and hypoxemia that improves when lying down is HPS. Diagnose with bubble-contrast echo showing delayed left-atrial bubbles. Treatment is a liver transplant.